BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10389117)

  • 1. L-NAME, a nitric oxide synthase inhibitor, modulates cholinergic antinociception.
    Jain NK; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1999 Apr; 21(3):161-5. PubMed ID: 10389117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide synthase inhibitors enhance the antinociceptive effects of oxotremorine in mice.
    Pavone F; Capone F; Populin R; Przewłocka B
    Pol J Pharmacol; 1997; 49(1):31-6. PubMed ID: 9431549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinociceptive effect of sumatriptan in mice.
    Jain NK; Kulkarni SK
    Indian J Exp Biol; 1998 Oct; 36(10):973-9. PubMed ID: 10356959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinergic-NO-cGMP mediation of sildenafil-induced antinociception.
    Patil CS; Jain NK; Singh VP; Kulkarni SK
    Indian J Exp Biol; 2004 Apr; 42(4):361-7. PubMed ID: 15088685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the endothelium and nitric oxide on the contractile responses evoked by 5-HT1D receptor agonists in the rabbit isolated saphenous vein.
    Valentin JP; Bonnafous R; John GW
    Br J Pharmacol; 1996 Sep; 119(1):35-42. PubMed ID: 8872354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antinociceptive activity of Muntingia calabura aqueous extract and the involvement of L-arginine/nitric oxide/cyclic guanosine monophosphate pathway in its observed activity in mice.
    Zakaria ZA; Sulaiman MR; Jais AM; Somchit MN; Jayaraman KV; Balakhrisnan G; Abdullah FC
    Fundam Clin Pharmacol; 2006 Aug; 20(4):365-72. PubMed ID: 16867020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation by nitric oxide synthase inhibitor and calcium channel blocker of aspartame-induced antinociception in the mouse formalin test.
    Abdollahi M; Nikfar S; Abdoli N
    Fundam Clin Pharmacol; 2001 Apr; 15(2):117-23. PubMed ID: 11468021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin and pain: evidence that activation of 5-HT1A receptors does not elicit antinociception against noxious thermal, mechanical and chemical stimuli in mice.
    Millan MJ
    Pain; 1994 Jul; 58(1):45-61. PubMed ID: 7970839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sildenafil, a phosphodiesterase-5 inhibitor, enhances the antinociceptive effect of morphine.
    Jain NK; Patil CS; Singh A; Kulkarni SK
    Pharmacology; 2003 Mar; 67(3):150-6. PubMed ID: 12571411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification by L-NAME of codeine induced analgesia: possible role of nitric oxide.
    Khattab MM; El-Hadiyah TM; Al-Shabanah OA; Raza M
    Recept Channels; 2004; 10(5-6):139-45. PubMed ID: 15989078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of L-arginine/nitric oxide pathway in the antinociceptive activity of pyridoxine in mouse.
    Abacioğlu N; Tunçtan B; Cakici I; Akbulut E; Uludağ O; Kanzik I
    Arzneimittelforschung; 2001 Oct; 51(10):832-8. PubMed ID: 11715636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contractile responses evoked by dihydroergotamine, naratriptan and sumatriptan in the canine isolated coronary artery.
    Valentin JP; Bonnafous R; John GW
    Fundam Clin Pharmacol; 1998; 12(2):152-7. PubMed ID: 9565768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a nitric oxide synthase inhibitor on 5-HT1A receptor agonist 8-OH-DPAT-induced hyperphagia in rats.
    Yamada J; Sugimoto Y; Yoshikawa T; Horisaka K
    Eur J Pharmacol; 1996 Nov; 316(1):23-6. PubMed ID: 8982645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of nitric oxide synthase inhibitor on antinociceptive effects of mu-opioid agonist in mice.
    Chena LX; Qia YM; Wangb R; Duan X; Gao YF; Yang DJ
    Protein Pept Lett; 2006; 13(10):993-7. PubMed ID: 17168821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antinociceptive effect and mechanisms of action of pregabalin in mice.
    Kaygisiz B; Kilic FS; Senguleroglu N; Baydemir C; Erol K
    Pharmacol Rep; 2015 Feb; 67(1):129-33. PubMed ID: 25560586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of caffeine coadministration and of nitric oxide synthesis inhibition on the antinociceptive action of ketorolac.
    López-Muñoz FJ; Castañeda-Hernández G; Flores-Murrieta FJ; Granados-Soto V
    Eur J Pharmacol; 1996 Jul; 308(3):275-7. PubMed ID: 8858298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-NAME causes antinociception by stimulation of the arginine-NO-cGMP pathway.
    Duarte ID; Ferreira SH
    Mediators Inflamm; 2000; 9(1):25-30. PubMed ID: 10877451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the antinociceptive effects of sodium nitroprusside and molsidomine in mice.
    Fidecka S; Lalewicz S
    Pol J Pharmacol; 1997; 49(6):395-400. PubMed ID: 9566042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ketamine activates the L-arginine/Nitric oxide/cyclic guanosine monophosphate pathway to induce peripheral antinociception in rats.
    Romero TR; Galdino GS; Silva GC; Resende LC; Perez AC; Côrtes SF; Duarte ID
    Anesth Analg; 2011 Nov; 113(5):1254-9. PubMed ID: 21788321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canine renovascular responses to sumatriptan and 5-carboxamidotryptamine: modulation through endothelial 5-HT1-like receptors by endogenous nitric oxide.
    Whiting MV; Cambridge D
    Br J Pharmacol; 1995 Mar; 114(5):969-74. PubMed ID: 7780652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.